Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathological complete response in an advance stage IIIB non-small cell lung cancer secondary to neoadjuvant osimertinib targeted therapy: A case report and review of literature.
Soo CI, Ong DB, Chin KK, Sia LC, Munusamy V, Ibrahim NH, Loh TC, Tan JL, Poh ME, Wong CK, Pang YK, Liam CK. Soo CI, et al. Among authors: chin kk. Respirol Case Rep. 2023 Jun 21;11(7):e01181. doi: 10.1002/rcr2.1181. eCollection 2023 Jul. Respirol Case Rep. 2023. PMID: 37350988 Free PMC article.
Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis.
Mac Aogáin M, Ivan FX, Jaggi TK, Richardson H, Shoemark A, Narayana JK, Dicker AJ, Koh MS, Lee KCH, Thun How O, Poh ME, Chin KK, Hou ALY, Ser Hon P, Low TB, Abisheganaden JA, Dimakou K, Digalaki A, Kosti C, Gkousiou A, Hansbro PM, Blasi F, Aliberti S, Chalmers JD, Chotirmall SH. Mac Aogáin M, et al. Among authors: chin kk. Am J Respir Crit Care Med. 2024 Jul 1;210(1):47-62. doi: 10.1164/rccm.202306-1059OC. Am J Respir Crit Care Med. 2024. PMID: 38271608 Free PMC article.
Ibrutinib for therapy of steroid-refractory chronic graft vs. host disease: A multicenter real-world analysis.
Pidala JA, Kim J, Kalos D, Cutler CS, DeFilipp Z, Flowers ME, Hamilton BK, Chin KK, Rotta M, El Jurdi N, Hamadani M, Ahmed G, Kitko CL, Ponce DM, Sung AD, Tang H, Farhadfar N, Nemecek ER, Pusic I, Qayed M, Rangarajan HG, Hogan WJ, Etra AM, Jaglowski SM. Pidala JA, et al. Among authors: chin kk. Blood Adv. 2024 Oct 25:bloodadvances.2024014374. doi: 10.1182/bloodadvances.2024014374. Online ahead of print. Blood Adv. 2024. PMID: 39454280
HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML.
Chin KK, Derkach A, Famulare C, Gupta GK, Borge PD, Geyer MB, Goldberg AD, Haque T, Park JH, Roeker LE, Tallman MS, Stahl M, Stein EM. Chin KK, et al. Leuk Lymphoma. 2024 Oct 14:1-9. doi: 10.1080/10428194.2024.2411436. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39397429
E-HeaRT BPA: electronic health record telemetry BPA.
Chin KK, Svec D, Leung B, Sharp C, Shieh L. Chin KK, et al. Postgrad Med J. 2020 Sep;96(1139):556-559. doi: 10.1136/postgradmedj-2019-137421. Epub 2020 May 28. Postgrad Med J. 2020. PMID: 32467108 Clinical Trial.
35 results